
Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico
A small California biotech emerged from stealth last year to go after drug discovery’s “data problem,” and now the AI outfit has announced its first public partnership.
Terray Therapeutics put out word Wednesday that it reached a deal with Calico Life Sciences, the Google-backed anti-aging biotech co-founded by industry legend, billionaire and current CEO Art Levinson, the former head over at Genentech and current chairman at Apple.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.